Compound ID | 2964
Class: DNA synthesis inhibitor
Spectrum of activity: | Gram-positive & Gram-negative |
Details of activity: | Active against Acinetobacter baumannii, Clostridium difficile, Enterobacter cloacae, Enterococcus faecium, Enterococcus faecalis, Escherichia coli, Haemophilus influenzae, Klebsiella pneumoniae, Neisseria gonorrhoeae, Pseudomonas aeruginosa, Staphylococcus aureus, Streptococcus pneumoniae, Bacillus anthracis, Francisella tularensis, and Yersinia pestis; bacterial topoisomerase inhibitor |
Description: | Synthetic compound; cytotoxicity (IC50) towards mammalian cell line HepG2 at 38 ug/ml vs MIC at 4-0.12 ug/ml |
Institute where first reported: | Redx Pharma, Alderley Park, Cheshire, United Kingdom |
Year first mentioned: | 2017 |
Development status: | Experimental |
Chemical structure(s): | |||||||||||
|
|
External links: | |
Citation: | https://journals.asm.org/doi/10.1128/aac.02100-16 |